Clinical Trial Update: A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab plus epacadostat with platinum-based chemotherapy versus pembrolizumab with platinum chemotherapy plus placebo in metasta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Epacadostat (epacadostat)
• Pembrolizumab (pembrolizumab)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Incyte Corporation | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-01-29